Skip to main content

Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030

AstraZeneca CEO Pascal Soriot discussed his company's ambitious revenue goal with CNBC's Jim Cramer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.